The flying gynaecologist, Dr Marc Perdu from New Caledonia, had been flying his single-engine light aircraft around the world to spread the importance of cervical cancer vaccination. He had been doing this since 2011. His latest trip was from Paris to Noumea.

And now, he is in Australia. But apart from his trips to other countries, he was here in the country because he was motivated by a research being conducted by the Royal Women's Hospital.

The Royal Women's Hospital was the very first group to be successful in carrying out the Human Papillomavirus Vaccination Programme. The programme had decreased pre-cancer HPV viruses by 77 per cent.

Australia has the most successful school-based vaccination programme which Dr Perdu wanted to imitate for New Caledonia.

Mr Perdu had talked with Professor Suzanne Garland, director of Centre for Infectious Disease at The Women's, to particularly seek out information about the Australian-made vaccine, Gardasil.

"Australia is ahead of the world because it's been given through a school-based system with 73 per cent of school-aged girls receiving the three doses,'' Ms Garland said.

Gardasil is a vaccine that shields people against two types of HPV that cause 70 per cent cervical cancers in women and 90 per cent cancers in men. The vaccine is also effective against the third type of HPV which caused 90 per cent of genital warts.

Mr Perdu was so convinced about Gardasil. He showed optimism that they can get enough budget to purchase and bring home Gardasil. He would just have to convince the people of New Caledonia that Gardasil is the right vaccine for HPV.

Meanwhile, the Women's Hospital is continuing its research probing the effectiveness of Gardasil.

Unvaccinated women, between the ages of 18-25 years old and residing in Victoria, are encouraged to participate for the study.

For those interested they would just have to fill out an online questionnaire.

The programme is titled: The Vaccine Against Cervical Cancer Impact and Effectiveness Study. It is funded by the Victorian Cancer Agency and being conducted by doctors from The Royal Women's Hospital, Murdoch Children's Research Institute and Victorian Cytology Service.